Shaanxi Suprbio Co., Ltd.

Purity: 99%
CAS NO.: 120511-73-1
Appearance: White powder
Grade: Pharmaceuticals Ingredients

Anastrozole is a potent selective triazole aromatase inhibitor that inhibits cytochrome P-450 dependent aromatase and thus blocks estrogen biosynthesis, the major Chemicalbook factor that stimulates breast cancer cell growth.  The 50% inhibitory concentration (IC50) value of aromatase against human placenta is 15nmol/L.  Letrozole is indicated for postmenopausal advanced breast cancer and is used as second-line therapy for patients who have failed anti-estrogen therapy.

Third generation aromatase inhibitors.  It’s used to treat postmenopausal women with advanced breast cancer.  A potent, selective triazole aromatase inhibitor that inhibits cytochrome P-450 dependent aromatase and thus inhibits Chemicalbook estrogen biosynthesis, a major factor in stimulating breast cancer cell growth.  For the treatment of breast cancer, it is especially suitable for advanced breast cancer in women who have relapsed after menopause after hormone-assisted therapy.